Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Psychosocial interventions for schizophrenia

Juan Bustillo, MD
Elizabeth Weil, MD
Section Editor
Stephen Marder, MD
Deputy Editor
Richard Hermann, MD


Schizophrenia is a psychiatric disorder involving chronic or recurrent psychosis. It is commonly associated with impairments in social and occupational functioning. [1]. It is among the most disabling and economically catastrophic medical disorders, ranked by the World Health Organization as one of the top ten illnesses contributing to the global burden of disease [2].

Antipsychotic medications are first-line treatment for schizophrenia. They have been shown in clinical trials to be effective in reducing symptoms and behaviors associated with the disorder. However, most patients with schizophrenia experience disabling impairment even after benefiting from antipsychotics, including positive and negative symptoms, cognitive deficits, poor social functioning, and episodes of acute symptomatic relapse. Empirically validated psychosocial interventions, added to antipsychotic medication, target one or more of these deficit areas.

This topic addresses psychosocial interventions for schizophrenia. Psychosocial interventions for severe mental illness (not limited to schizophrenia), including assertive community treatment and supported employment, are discussed separately. The epidemiology, pathogenesis, clinical presentation, clinical manifestations, course, diagnosis and pharmacotherapy for schizophrenia are also discussed separately. Common comorbid presentations of schizophrenia are also discussed separately. (See "Psychosocial interventions for severe mental illness", section on 'Efficacy' and "Schizophrenia in adults: Epidemiology and pathogenesis" and "Schizophrenia in adults: Clinical manifestations, course, assessment, and diagnosis" and "Depression in schizophrenia" and "Anxiety in schizophrenia" and "Co-occurring schizophrenia and substance use disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment and diagnosis" and "Pharmacotherapy for schizophrenia: Acute and maintenance phase treatment" and "Pharmacotherapy for schizophrenia: Long-acting injectable antipsychotic drugs".)


Following treatment with antipsychotic medication, which is often only partially effective, most individuals with schizophrenia would benefit from systematic rehabilitation. This may include family interventions, social skills training, and/or cognitive behavioral therapy, which are discussed in this topic, as well as assertive community treatment and supported employment, which are discussed separately. (See "Psychosocial interventions for severe mental illness".)

Psychosocial interventions are indicated for patients with schizophrenia and the characteristics that follow as an adjunct to antipsychotic medication:

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Nov 2017. | This topic last updated: Oct 13, 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), American Psychiatric Association, Arlington 2013.
  2. Murray CJL, Lopez AD. The Global Burden of Disease, Harvard University Press, Cambridge, MA 1996. p.21.
  3. Butzlaff RL, Hooley JM. Expressed emotion and psychiatric relapse: a meta-analysis. Arch Gen Psychiatry 1998; 55:547.
  4. Wood BL, Miller BD, Lim J, et al. Family relational factors in pediatric depression and asthma: pathways of effect. J Am Acad Child Adolesc Psychiatry 2006; 45:1494.
  5. Schooler NR, Keith SJ, Severe JB, et al. Relapse and rehospitalization during maintenance treatment of schizophrenia. The effects of dose reduction and family treatment. Arch Gen Psychiatry 1997; 54:453.
  6. Álvarez-Jiménez M, Gleeson JF, Henry LP, et al. Road to full recovery: longitudinal relationship between symptomatic remission and psychosocial recovery in first-episode psychosis over 7.5 years. Psychol Med 2012; 42:595.
  7. Falloon IR, Boyd JL, McGill CW, et al. Family management in the prevention of exacerbations of schizophrenia: a controlled study. N Engl J Med 1982; 306:1437.
  8. Falloon IR, Boyd JL, McGill CW, et al. Family management in the prevention of morbidity of schizophrenia. Clinical outcome of a two-year longitudinal study. Arch Gen Psychiatry 1985; 42:887.
  9. Dixon LB, Dickerson F, Bellack AS, et al. The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. Schizophr Bull 2010; 36:48.
  10. Pharoah F, Mari J, Rathbone J, Wong W. Family intervention for schizophrenia. Cochrane Database Syst Rev 2010; :CD000088.
  11. Buchanan RW, Javitt DC, Marder SR, et al. The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments. Am J Psychiatry 2007; 164:1593.
  12. Kurtz MM, Mueser KT. A meta-analysis of controlled research on social skills training for schizophrenia. J Consult Clin Psychol 2008; 76:491.
  13. Bellack AS, Mueser KT. Psychosocial treatment for schizophrenia. Schizophr Bull 1993; 19:317.
  14. Eckman TA, Wirshing WC, Marder SR, et al. Technique for training schizophrenic patients in illness self-management: a controlled trial. Am J Psychiatry 1992; 149:1549.
  15. Bellack AS, Mueser K, Gingerich S, Agresta J. Social Skills Training for Schizophenia: A step-by step guide, 2nd ed., The Guilford Press, New York 2004.
  16. Turner DT, van der Gaag M, Karyotaki E, Cuijpers P. Psychological interventions for psychosis: a meta-analysis of comparative outcome studies. Am J Psychiatry 2014; 171:523.
  17. Vinogradov S, Fisher M, de Villers-Sidani E. Cognitive training for impaired neural systems in neuropsychiatric illness. Neuropsychopharmacology 2012; 37:43.
  18. Wykes T, Huddy V, Cellard C, et al. A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. Am J Psychiatry 2011; 168:472.
  19. Fisher M, Holland C, Merzenich MM, Vinogradov S. Using neuroplasticity-based auditory training to improve verbal memory in schizophrenia. Am J Psychiatry 2009; 166:805.
  20. Kingdon DG, Turkington D. Cognitive-Behavioral Therapy of Schizophrenia, Guilford Publications, New York 2002.
  21. Jauhar S, McKenna PJ, Radua J, et al. Cognitive-behavioural therapy for the symptoms of schizophrenia: systematic review and meta-analysis with examination of potential bias. Br J Psychiatry 2014; 204:20.
  22. Naeem F, Farooq S, Kingdon D. Cognitive behavioral therapy (brief vs standard duration) for schizophrenia. Schizophr Bull 2014; 40:958.
  23. Wykes T, Steel C, Everitt B, Tarrier N. Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophr Bull 2008; 34:523.
  24. Jones C, Hacker D, Cormac I, et al. Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia. Cochrane Database Syst Rev 2012; :CD008712.
  25. Gumley A, O'Grady M, McNay L, et al. Early intervention for relapse in schizophrenia: results of a 12-month randomized controlled trial of cognitive behavioural therapy. Psychol Med 2003; 33:419.
  26. Moritz S, Veckenstedt R, Andreou C, et al. Sustained and "sleeper" effects of group metacognitive training for schizophrenia: a randomized clinical trial. JAMA Psychiatry 2014; 71:1103.
  27. Moritz S, Veckenstedt R, Bohn F, et al. Complementary group Metacognitive Training (MCT) reduces delusional ideation in schizophrenia. Schizophr Res 2013; 151:61.
  28. Garety PA, Craig TK, Dunn G, et al. Specialised care for early psychosis: symptoms, social functioning and patient satisfaction: randomised controlled trial. Br J Psychiatry 2006; 188:37.
  29. Thorup A, Petersen L, Jeppesen P, et al. Integrated treatment ameliorates negative symptoms in first episode psychosis--results from the Danish OPUS trial. Schizophr Res 2005; 79:95.
  30. Petersen L, Jeppesen P, Thorup A, et al. A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness. BMJ 2005; 331:602.
  31. Srihari VH, Tek C, Kucukgoncu S, et al. First-Episode Services for Psychotic Disorders in the U.S. Public Sector: A Pragmatic Randomized Controlled Trial. Psychiatr Serv 2015; 66:705.
  32. Kane JM, Robinson DG, Schooler NR, et al. Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program. Am J Psychiatry 2016; 173:362.